Latest | F'cast | |
---|---|---|
Div Yield | 0.8% | |
Div Cover | 4.0 | |
Op Mrgn | 23.6% | |
ROCE | 33.1% |
Latest | F'cast | |
---|---|---|
P/E | 29.8 | |
PEG | 0.1 | |
Pr/Revenue | 5.7 | |
Pr/Book | 3.2 |
Latest | F'cast | |
---|---|---|
Revenue | 15.3% | |
PBT | 163.7% | |
EPS | 209.9% | |
DPS | 2.2% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 6,735.18 | 1,387.36 | 737.57¢ | 22.6 | 0.7 | +32% | 141.81¢ | 0.0% |
31-Dec-26 | 7,619.10 | 1,915.52 | 925.76¢ | 18.0 | 0.7 | +26% | 146.23¢ | 0.0% |
31-Dec-27 | 8,493.34 | 2,483.21 | 1,207.96¢ | 13.8 | 0.5 | +30% | 149.57¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Currency | Euro |
Share Price | 167.71 |
Change Today | 0.76 |
% Change | 0.45 % |
52 Week High | 196.80 |
52 Week Low | 129.35 |
Volume | 2,300 |
Shares Issued | 190.00m |
Market Cap | 31,864m |
Beta | 1.55 |
Strong Buy | 6 |
Buy | 9 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 20 |
Time | Volume / Share Price |
09:02 | 5 @ 167.75 |
09:02 | 9 @ 167.75 |
09:02 | 2 @ 167.95 |
09:02 | 21 @ 167.75 |
09:02 | 74 @ 167.60 |
You are here: research